Tenofovir DF 300 mg
Tenofovir Disoproxil Fumarate (Tenofovir DF) 300 mg Tablets are a nucleos(t)ide reverse transcriptase inhibitor widely used as a backbone agent in antiretroviral therapy, contributing to effective viral suppression in the management of HIV-1 infection under recommended treatment frameworks.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitor (NtRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets
Tenofovir DF 300 mg
Tenofovir Disoproxil Fumarate (Tenofovir DF) 300 mg Tablets are a nucleos(t)ide reverse transcriptase inhibitor widely used as a backbone agent in antiretroviral therapy, contributing to effective viral suppression in the management of HIV-1 infection under recommended treatment frameworks.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitor (NtRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets
Tenofovir DF 300 mg
Tenofovir Disoproxil Fumarate (Tenofovir DF) 300 mg Tablets are a nucleos(t)ide reverse transcriptase inhibitor widely used as a backbone agent in antiretroviral therapy, contributing to effective viral suppression in the management of HIV-1 infection under recommended treatment frameworks.
Product Details
Therapeutic Class
Nucleos(t)ide Reverse Transcriptase Inhibitor (NtRTI)
Indication
Treatment of HIV-1 infection in adults and adolescents as part of combination antiretroviral therapy (ART), in accordance with WHO and NACO recommendations.
Dosage & Administration
300 mg once daily, or as prescribed by a healthcare professional.
To be used strictly as part of a combination ART regimen.
Storage
Store below 30°C in a dry place, protected from light and moisture.
Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO and NACO treatment guidelines.
Pack Size
30 tablets